Please login to the form below

Not currently logged in
Email:
Password:

New US head for Daiichi Sankyo

Glenn Gormley replaces John Gargiulo who steps down as president and CEO

Daiichi Sankyo Glenn Gormley Daiichi Sankyo has announced a shake-up of its senior leadership team in the US.

John Gargiulo well step down as president and CEO of the group's US subsidiary Daiichi Sankyo Inc to be replaced by Dr Glenn Gormley, who takes on the role of president and chairman.

Dr Gormley (pictured right) will also continue in his existing roles as president, Daiichi Sankyo pharma development; global head of R&D; and senior executive officer.

In addition to the announcement that Gargiulo is to step down as president and CEO, he will also leave his role as head of Daiichi's commercial division. He is succeeded there by Greg Barrett, who now holds the title of acting president, Daiichi Sankyo administrative and commercial operations.

The move is a step up for Barrett, who most recently held the position of VP, marketing and managed markets in the US.

No reason was given for the departure of Gargiulo who has been with the company in the US since 1996.

8th October 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics